Profile data is unavailable for this security.
About the company
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
- Revenue in NOK (TTM)123.00k
- Net income in NOK9.51m
- Incorporated2010
- Employees8.00
- LocationCircio Holding ASAVollsveien 19LYSAKER 1366NorwayNOR
- Phone+47 21398810
- Fax+47 67122658
- Websitehttps://www.circio.com/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2cureX AB | 90.15k | -27.30m | 10.58m | 14.00 | -- | 3.67 | -- | 117.35 | -1.50 | -1.50 | 0.0049 | 0.1582 | 0.0047 | -- | 0.0295 | 6,214.29 | -143.13 | -38.93 | -174.78 | -44.42 | -10,942.53 | -22,717.96 | -30,282.76 | -39,378.78 | -- | -13.61 | 0.00 | -- | 72.22 | -- | -9.23 | -- | -57.30 | -- |
ATTANA AB | 5.33m | -12.62m | 12.94m | 10.00 | -- | 0.7714 | -- | 2.43 | -0.0361 | -0.0361 | 0.0148 | 0.0376 | 0.1715 | -0.4127 | 1.97 | 514,073.00 | -40.63 | -37.18 | -62.57 | -46.66 | 127.26 | 175.97 | -236.92 | -254.69 | 0.4858 | -4.43 | 0.158 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
Diagonal Bio AB | 23.83k | -12.04m | 14.53m | 4.00 | -- | 0.4974 | -- | 609.78 | -0.1407 | -0.1407 | 0.0002 | 0.0704 | 0.0008 | -- | 2.00 | 4,600.00 | -38.99 | -- | -43.85 | -- | -32,443.48 | -- | -50,504.35 | -- | 1.72 | -15.50 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
Circio Holding ASA | 123.00k | 9.51m | 15.15m | 8.00 | 0.904 | -- | 1.47 | 123.20 | 0.6836 | 0.6836 | 0.0156 | -4.05 | 0.0043 | -- | 0.0145 | 11,181.82 | 33.11 | -46.58 | -- | -53.40 | -- | -- | 7,730.08 | -6,902.00 | -- | -- | -- | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
Gabather AB | 0.00 | -11.07m | 15.98m | -- | -- | -- | -- | -- | -0.6373 | -0.6373 | 0.00 | -0.1818 | 0.00 | -- | -- | -- | -192.36 | -56.57 | -- | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
Lidds AB | 0.00 | -26.53m | 16.26m | 1.00 | -- | 2.03 | -- | -- | -0.4664 | -0.4664 | 0.00 | 0.0566 | 0.00 | -- | -- | 0.00 | -97.07 | -46.33 | -111.99 | -51.61 | -- | -1,934.24 | -- | -3,076.68 | -- | -- | 0.1044 | -- | -100.00 | -- | -9.08 | -- | -- | -- |
Aptahem AB | 0.00 | -11.63m | 23.19m | -- | -- | 0.3554 | -- | -- | -3.41 | -3.41 | 0.00 | 11.11 | 0.00 | -- | -- | -- | -16.56 | -39.26 | -18.26 | -44.19 | -- | -- | -- | -- | -- | -8.34 | 0.00 | -- | -- | -- | -25.36 | -- | -- | -- |
Stayble Therapeutics AB | 0.00 | -21.14m | 30.81m | 2.00 | -- | 2.43 | -- | -- | -0.6413 | -0.6413 | 0.00 | 0.2795 | 0.00 | -- | -- | 0.00 | -81.91 | -78.64 | -93.24 | -95.58 | -- | -- | -- | -- | -- | -- | 0.065 | -- | -- | -- | 3.22 | -- | -- | -- |
Scandion Oncology A/S | 0.00 | -56.68m | 33.50m | 4.00 | -- | 0.6901 | -- | -- | -0.3738 | -0.3738 | 0.00 | 0.202 | 0.00 | -- | -- | 0.00 | -72.35 | -- | -84.88 | -- | -- | -- | -- | -- | -- | -- | 0.0058 | -- | -- | -- | 48.89 | -- | -- | -- |
SoftOx Solutions AS | 1.66m | -60.58m | 34.73m | 7.00 | -- | 0.2323 | -- | 20.92 | -0.7729 | -0.7729 | 0.0022 | 0.0766 | 0.0166 | -- | 0.493 | 237,141.40 | -60.65 | -50.11 | -81.43 | -63.61 | -- | -- | -3,649.40 | -639.34 | 0.4049 | -2.76 | 0.1463 | -- | -1.88 | 10.06 | 44.55 | -- | 39.43 | -- |
Peptonic Medical AB | 40.47m | -46.89m | 35.78m | 37.00 | -- | 0.1855 | -- | 0.8843 | -0.025 | -0.025 | 0.0222 | 0.0323 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
Fluicell AB | 1.34m | -28.15m | 37.03m | 11.00 | -- | 1.66 | -- | 27.55 | -0.1493 | -0.1493 | 0.0055 | 0.045 | 0.0525 | 0.5265 | 1.98 | 76,294.12 | -109.94 | -87.55 | -141.87 | -126.02 | -17.66 | 72.97 | -2,094.37 | -650.23 | 3.83 | -695.51 | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Storebrand Asset Management ASas of 30 Jun 2024 | 21.39k | 0.20% |